Bortezomib + Bortezomib Mannitol Ester

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Bortezomib bortezomib
Bortezomib Mannitol Ester bortezomib-mannitol-ester

Brands with this exact combination

Brand	Composition & strength	Manufacturer
BORTEZOMIB ACCORDAU CZ ES EU LV	injection ×6 Bortezomib Mannitol Ester injection ×6 Bortezomib 2.5 mg/1 mL injection ×4 Bortezomib 3.5 mg injection ×3 Bortezomib 1 mg Other 2 compositions	Accord Healthcare S.L.U., Barcelona
VELCADEAU CA CZ ES EU LV MX US	injection ×5 Bortezomib 3.5 mg injection ×2 Bortezomib Mannitol Ester unknown ×2 Bortezomib injection Bortezomib 1 mg	Janssen-Cilag International N.V., Beerse
BORTEZOMIB EVER PHARMAAU CZ ES	injection ×4 Bortezomib Mannitol Ester injection ×2 Bortezomib 2.5 mg/1 mL unknown Bortezomib injection Bortezomib 3.5 mg/1.4 mL	EVER-Valinject GmbH, Unterach am Attersee
BORTEZOMIB FRESENIUS KABICZ ES EU LV	injection ×3 Bortezomib Mannitol Ester injection ×2 Bortezomib 3.5 mg unknown Bortezomib injection Bortezomib 1 mg Other 1 compositions	Fresenius Kabi Deutschland GmbH, Bad Homburg
BORTEZOMIB SUNCZ ES EU LV	injection ×2 Bortezomib 3.5 mg injection Bortezomib Mannitol Ester unknown Bortezomib	Sun Pharmaceutical Industries (Europe) B.V.

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.